Please do not leave this page until complete. This can take a few moments.
ImmuCell Corp. (Nasdaq: ICCC), a Portland biotech company that makes preventive health products for beef and dairy cattle, on Thursday reported that its sales for the year’s third quarter increased 25% over the same period in 2019.
Sales rose $752,000 to $3.7 million during the three-month period that ended Sept. 30, 2020.
For the first nine months of the year, sales totaled $11.6 million, an increase of 15% or $1.5 million, over that period in 2019.
The company reported a loss of $323,000, or 4 cents per share, during this year’s third quarter, in comparison to net loss of $503,000, or 7 cents per share for the quarter last year. For the nine-month period in 2020, ImmuCell had a loss of $1.2 million, or 17 cents per share, in comparison to loss of $985,000, or 15 cents per share, last year.
The company also noted that a $937,700 loan received under the Paycheck Protection Program was recorded as a liability for the third quarter of 2020. Since then, ImmuCell has received notice that the loan has been fully forgiven and the amount is expected to be recognized as other income during the fourth quarter.
ImmuCell President and CEO Michael F. Brigham commented on the quarterly results in a news release, saying, “As indicated by the top line growth, our sales team continues to be productive and healthy despite COVID-19’s impact on the economy.
“We are making measurable progress in expanding our First Defense business. We reduced the backlog of orders and expect to fully realize the benefits of our expanded production capacity beginning in the second quarter of 2021.”
Shares of ImmuCell were trading at around $5.66 late Friday morning, almost unchanged from yesterday’s close.
The Giving Guide helps nonprofits have the opportunity to showcase and differentiate their organizations so that businesses better understand how they can contribute to a nonprofit’s mission and work.
Learn MoreWork for ME is a workforce development tool to help Maine’s employers target Maine’s emerging workforce. Work for ME highlights each industry, its impact on Maine’s economy, the jobs available to entry-level workers, the training and education needed to get a career started.
Learn MoreFew people are adequately prepared for all the tasks involved in planning and providing care for aging family members. SeniorSmart provides an essential road map for navigating the process. This resource guide explores the myriad of care options and offers essential information on topics ranging from self-care to legal and financial preparedness.
Learn moreThe Giving Guide helps nonprofits have the opportunity to showcase and differentiate their organizations so that businesses better understand how they can contribute to a nonprofit’s mission and work.
Work for ME is a workforce development tool to help Maine’s employers target Maine’s emerging workforce. Work for ME highlights each industry, its impact on Maine’s economy, the jobs available to entry-level workers, the training and education needed to get a career started.
Few people are adequately prepared for all the tasks involved in planning and providing care for aging family members. SeniorSmart provides an essential road map for navigating the process. This resource guide explores the myriad of care options and offers essential information on topics ranging from self-care to legal and financial preparedness.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments